Prescription drug pricing, including MDRP. Substance Use Disorder Policy. Implementation of Inflation Reduction Act. Patient access.
2026 · 3rd Quarter (July 1 - Sep 30)
ALKERMES, INC.
Filed by TODD STRATEGY GROUP.
Open official filingSource-reported fields
Filing overview
- Type
- 3rd Quarter - Report
- Posted
- Oct 20, 2026
- Income
- $60,000.00
- Expenses
- Not reported
- Registrant
- TODD STRATEGY GROUP
- Client
- ALKERMES, INC.
- Filing UUID
- 479ab876-530d-4cdc-8ec2-995c169adf65
- Termination date
- Not reported
Literal source text
Lobbying issues and bill citations
Maintaining six protected classes for bipolar disorders and schizophrenia under Medicare Part D.
Relationship and amount limits
Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.